Letters
Adverse effects of statins
Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g4028 (Published 18 June 2014) Cite this as: BMJ 2014;348:g4028
- Tom Fahey, professor of general practice1,
- Susan Smith, associate professor of general practice1
- 1Royal College of Surgeons in Ireland Medical School, Dublin 2, Republic of Ireland
- tomfahey{at}rcsi.ie
Abramson and colleagues highlight uncertainties about adverse effects of statins for the primary prevention of cardiovascular disease in patients at low absolute cardiovascular risk.1 2 There is a substantial discrepancy between observational studies and randomised controlled trials (RCTs) regarding the reporting of adverse effects of statins. This could be the result of under-reporting of “mild” adverse effects in RCTs …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.